Autoimmune hepatitis (AH) and primary biliary cirrhosis (PBC) are autoimmune diseases (AIDs) targeting cellular components of the liver. Being rare diseases, limited data are available about familial risks among these AIDs (concordant) or between them and other AIDs (discordant). We aimed to carry out an unbiased study on these AIDs based on medically diagnosed patients. We collected data on patients diagnosed in Swedish hospitals with AH, PBC and other AIDs and calculated familial standardized incidence ratios (SIRs) for concordant and discordant familial relative risks. The number of AH patients was 6,269, of whom 43.0% were male; patient numbers for PBC were 4,269, with 17.8% males. AH accounted for 0.8% and 0.6% of all hospitalized AIDs in Sweden. For AH only the familial risk between siblings was significant (3.83). For PBC the risks for offspring of parents (9.05) and siblings (10.88) were high, but only risk for females was significant. Spousal risks were very high, 5.91 and 6.07 for AH. Risk for AH was 2.21 in families of PBC, and it was 2.47 for PBC in families of AH patients. Among other AIDs, 14 showed a significant association with AH, compared to 16 AIDs with PBC. The surprising finding in this nation-wide family study on medically diagnosed patients was the high risk for AH (6.0) between spouses, which exceed the risk between siblings, suggesting the existence of strong environmental risk factors. AH and PBC were associated with multiple other AIDs. The results call attention to environmental factors in AID etiology which should also be in focus in taking anamnestic data from patients.

Center for Community based Healthcare Research and Education Department of Functional Pathology School of Medicine Shimane University Matsue Japan

Center for Primary Health Care Research Lund University Malmö Sweden

Department of Family Medicine and Community Health Department of Population Health Science and Policy Icahn School of Medicine at Mount Sinai New York New York United States of America

Division of Cancer Epidemiology German Cancer Research Centre Heidelberg Germany

Division of Molecular Genetic Epidemiology German Cancer Research Centre Heidelberg Germany

Division of Pediatric Neurooncology German Cancer Research Center Heidelberg Germany

Faculty of Medicine and Biomedical Center in Pilsen Charles University Prague Pilsen Czech Republic

GeneWerk GmbH Heidelberg Germany

Hopp Children's Cancer Center Heidelberg Germany

Zobrazit více v PubMed

Gonzalez RS, Washington K. Primary Biliary Cholangitis and Autoimmune Hepatitis. Surgical pathology clinics. 2018;11(2):329–49. 10.1016/j.path.2018.02.010 PubMed DOI

Gronbaek L, Otete H, Ban L, Crooks C, Card T, Jepsen P, et al. Incidence, prevalence and mortality of autoimmune hepatitis in England 1997–2015. A population-based cohort study. Liver international: official journal of the International Association for the Study of the Liver. 2020. PubMed

Werner M, Prytz H, Ohlsson B, Almer S, Björnsson E, Bergquist A, et al. Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study. Scand J Gastroenterol. 2008;43(10):1232–40. 10.1080/00365520802130183 PubMed DOI

Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet (London, England). 2015;386(10003):1565–75. PubMed

Marschall HU, Henriksson I, Lindberg S, Soderdahl F, Thuresson M, Wahlin S, et al. Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort. Scientific reports. 2019;9(1):11525 10.1038/s41598-019-47890-2 PubMed DOI PMC

Tsuneyama K, Baba H, Morimoto Y, Tsunematsu T, Ogawa H. Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms. The journal of medical investigation: JMI. 2017;64(1.2):7–13. 10.2152/jmi.64.7 PubMed DOI

Corrigan M, Hirschfield GM, Oo YH, Adams DH. Autoimmune hepatitis: an approach to disease understanding and management. British medical bulletin. 2015;114(1):181–91. 10.1093/bmb/ldv021 PubMed DOI

Sahebjam F, Vierling JM. Autoimmune hepatitis. Frontiers of medicine. 2015;9(2):187–219. 10.1007/s11684-015-0386-y PubMed DOI

Primer NRD. Autoimmune hepatitis. Nature reviews Disease primers. 2018;4:18018 10.1038/nrdp.2018.18 PubMed DOI

Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis—Update 2015. J Hepatol. 2015;62(1 Suppl):S100–11. 10.1016/j.jhep.2015.03.005 PubMed DOI

Galoosian A, Hanlon C, Zhang J, Holt EW, Yimam KK. Clinical Updates in Primary Biliary Cholangitis: Trends, Epidemiology, Diagnostics, and New Therapeutic Approaches. Journal of clinical and translational hepatology. 2020;8(1):49–60. 10.14218/JCTH.2019.00049 PubMed DOI PMC

Gronbaek L, Vilstrup H, Pedersen L, Jepsen P. Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study. Liver international: official journal of the International Association for the Study of the Liver. 2019;39(1):205–14. PubMed

Gronbaek L, Vilstrup H, Pedersen L, Christensen K, Jepsen P. Family occurrence of autoimmune hepatitis: A Danish nationwide registry-based cohort study. J Hepatol. 2018;69(4):873–7. 10.1016/j.jhep.2018.05.035 PubMed DOI

Mells GF. Primary biliary cirrhosis: Family, genes, and bugs. Clinical liver disease. 2014;3(4):69–73. 10.1002/cld.308 PubMed DOI PMC

Ornolfsson KT, Olafsson S, Bergmann OM, Gershwin ME, Bjornsson ES. Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis. Hepatology (Baltimore, Md). 2018;68(1):166–71. PubMed

Tanaka A, Leung PSC, Gershwin ME. The genetics of primary biliary cholangitis. Current opinion in gastroenterology. 2019;35(2):93–8. 10.1097/MOG.0000000000000507 PubMed DOI

Hemminki K, Li X, Sundquist K, Sundquist J. Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden. Clin Exp Allergy. 2007;37:1320–5. 10.1111/j.1365-2222.2007.02737.x PubMed DOI

Hemminki K, Li X, Sundquist K, Sundquist J. High familial risks for cerebral palsy implicate partial heritable aetiology. Paediatr Perinat Epidemiol. 2007;21:235–41. 10.1111/j.1365-3016.2007.00798.x PubMed DOI

Hemminki K, Li X, Sundquist K, Sundquist J. Familial risks for common diseases: etiologic clues and guidance to gene identification Mutat Res Rev. 2008;658:247–58. PubMed

Hemminki K, Li X, Sundquist K, Sundquist J. Familial association of inflammatory bowel diseases with other autoimmune and related diseases. Am J Gastroenterol. 2010;105:139–47. 10.1038/ajg.2009.496 PubMed DOI

Hemminki K, Li X, Sundquist J, Sundquist K. Familial risks for amyotrophic lateral sclerosis and autoimmune diseases. Neurogenetics. 2009;10(2):111–6. 10.1007/s10048-008-0164-y PubMed DOI

Floreani A, Restrepo-Jiménez P, Secchi MF, De Martin S, Leung PSC, Krawitt E, et al. Etiopathogenesis of autoimmune hepatitis. Journal of autoimmunity. 2018;95:133–43. 10.1016/j.jaut.2018.10.020 PubMed DOI

Czaja AJ. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions. World journal of gastroenterology. 2019;25(45):6579–606. 10.3748/wjg.v25.i45.6579 PubMed DOI PMC

Ngu JH, Gearry RB, Frampton CM, Stedman CA. Autoimmune hepatitis: the role of environmental risk factors: a population-based study. Hepatology international. 2013;7(3):869–75. 10.1007/s12072-013-9448-x PubMed DOI

Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J. The Swedish Family-Cancer Database 2009: Prospects for histology-specific and immigrant studies. International journal of cancer. 2010;126:2259–67. 10.1002/ijc.24795 PubMed DOI

Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers